[1] O'Grady JG. Paracetamol-induced acute liver failure: prevention and management. J Hepatol. 1997, 26 Suppl 1:41-46.
[2] Huang L, Heinloth AN, Zeng ZB, et al. Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants. BMC Genomics. 2008, 9:288.
[3] Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis. 2002, 5:153-165.
[4] Muramatsu Y, Tsujie M, Kohda Y, et al. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int. 2002, 62:1601-1610.
[5] Klingenberg R, Aghlmandi S, Liebetrau C, et al. Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes. Eur Heart J. 2017, 38:3493-3502.
[6] Li ZQ, Wu WR, Zhao C, et al. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma. Int J Mol Med. 2018, 41:1518-1528.
[7] 武淑琴, 吴丹丹, 王新, 等. 不同剂量对乙酰氨基酚诱导大鼠急性肝损伤的研究. 黑龙江八一农垦大学学报. 2015, 27:40-43.
[8] 逯遥, 姜东莉, 刘洋, 等. 以还原型谷胱甘肽干预慢性酒精中毒动物模型升主动脉力学特性分析. 中国实验诊断学. 2018, 22:2154-2157.
[9] Lee WM. Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away?. J Hepatol. 2017, 67:1324-1331.
[10] Li C, Zhao L, Wang Y, et al. Cysteine-rich protein 61, a specific ultra-early biomarker in kidney ischemia/reperfusion injury. Nephrology (Carlton). 2019,24:798-805. |
